WO2012167112A9 - Gastric cancer biomarkers - Google Patents
Gastric cancer biomarkers Download PDFInfo
- Publication number
- WO2012167112A9 WO2012167112A9 PCT/US2012/040501 US2012040501W WO2012167112A9 WO 2012167112 A9 WO2012167112 A9 WO 2012167112A9 US 2012040501 W US2012040501 W US 2012040501W WO 2012167112 A9 WO2012167112 A9 WO 2012167112A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gastric cancer
- cancer biomarkers
- biomarkers
- gastric
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57446—Specifically defined cancers of stomach or intestine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161492061P | 2011-06-01 | 2011-06-01 | |
US61/492,061 | 2011-06-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012167112A2 WO2012167112A2 (en) | 2012-12-06 |
WO2012167112A9 true WO2012167112A9 (en) | 2013-03-07 |
Family
ID=47260389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/040501 WO2012167112A2 (en) | 2011-06-01 | 2012-06-01 | Gastric cancer biomarkers |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2012167112A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103954767B (en) * | 2014-04-02 | 2016-01-13 | 上海交通大学医学院附属仁济医院 | The novelty teabag that TRIM59 albumen is treated diagnosing gastric cancer |
WO2021062041A1 (en) * | 2019-09-24 | 2021-04-01 | Joshua Labaer | Novel antibodies for detecting gastric cancer |
CN111172271A (en) * | 2020-01-17 | 2020-05-19 | 中国辐射防护研究院 | Application of UIMC1 gene as molecular marker for judging susceptibility of radiation damage |
KR102281058B1 (en) * | 2020-07-10 | 2021-07-23 | 서울대학교병원 | Composition for predicting or diagnosing gastric cancer comprising detection agent of mutation of MUC4 gene |
-
2012
- 2012-06-01 WO PCT/US2012/040501 patent/WO2012167112A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2012167112A2 (en) | 2012-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3713825A4 (en) | Floating driller | |
HK1193637A1 (en) | Biomarkers for lung cancer | |
HK1197182A1 (en) | Cancer immunotherapy | |
WO2011163332A9 (en) | Methods for detecting cancer | |
EP2625292A4 (en) | Biomarkers of cancer | |
HK1206414A1 (en) | Biomarkers for gastric cancer and uses thereof | |
GB201016139D0 (en) | Cancer phosholipidome | |
EP2831270B8 (en) | Biomarker for bladder cancer | |
GB201120860D0 (en) | Cancer immunotherapy | |
GB2510539B (en) | Biomarkers of cancer | |
EP2753716A4 (en) | Novel risk biomarkers for lung cancer | |
WO2012167112A9 (en) | Gastric cancer biomarkers | |
HK1177502A1 (en) | Biomarker for gastric cancer | |
EP2883052B8 (en) | Biomarkers | |
EP2771943B8 (en) | Antenna arrangement | |
EP2673839A4 (en) | Antenna arrangement | |
AU2012900233A0 (en) | Biomarkers for gastric cancer and uses thereof | |
AU2011902612A0 (en) | Biomarkers | |
AU2010904219A0 (en) | Biomarkers | |
AU2011100483A4 (en) | EvacApp | |
AU2011100317A4 (en) | SecureShred | |
AU2011100311A4 (en) | GiftInACard | |
AU2011100245A4 (en) | Prochute | |
AU2011100090A4 (en) | Alcotagz | |
AU2011100047A4 (en) | Memoriade |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12792570 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12792570 Country of ref document: EP Kind code of ref document: A2 |